Quote:
Originally Posted by afc wimbledon
Really? a company promised total legal immunity and a multi billion dollar government contract by an administration that doesnt care if it works or not and is clear they dont care, who wouldnt take that deal? its a license to print money
|
A couple of issues with that:
-the money part has already happened. Governments around the world have already agreed to buy doses of these vaccines as long as they're effective, regardless of which gets approved first. There's very little marginal value a company rushing it to market for the US just to help Trump.
-these trials have publicly released standards and benchmarks that need to be achieved before they can move forward. Pharmaceutical companies with $25-50B a year in revenue aren't going to just throw that out the window, potentially ruin their reputation, and possibly mess up their chances of producing a useful vaccine for the other 7.5 billion people who don't live in the US just to get a few hundred million in extra revenue from the US.